Table of Contents
Introduction
Chondrosarcoma- Overview
Chondrosarcoma- Therapeutics Development
Chondrosarcoma- Therapeutics Assessment
Chondrosarcoma- Companies Involved in Therapeutics Development
Chondrosarcoma- Drug Profiles
Chondrosarcoma- Dormant Projects
Chondrosarcoma- Discontinued Products
Chondrosarcoma- Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Chondrosarcoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Chondrosarcoma - Pipeline by Aadi Bioscience Inc, H2 2020
Chondrosarcoma - Pipeline by Acrotech Biopharma LLC, H2 2020
Chondrosarcoma - Pipeline by Advenchen Laboratories LLC, H2 2020
Chondrosarcoma - Pipeline by Agios Pharmaceuticals Inc, H2 2020
Chondrosarcoma - Pipeline by Alkermes Plc, H2 2020
Chondrosarcoma - Pipeline by Astex Pharmaceuticals Inc, H2 2020
Chondrosarcoma - Pipeline by Atlanthera, H2 2020
Chondrosarcoma - Pipeline by Bayer AG, H2 2020
Chondrosarcoma - Pipeline by BioAtla LLC, H2 2020
Chondrosarcoma - Pipeline by BioMed Valley Discoveries Inc, H2 2020
Chondrosarcoma - Pipeline by Daiichi Sankyo Co Ltd, H2 2020
Chondrosarcoma - Pipeline by Eli Lilly and Co, H2 2020
Chondrosarcoma - Pipeline by ENB Therapeutics LLC, H2 2020
Chondrosarcoma - Pipeline by Epeius Biotechnologies Corp, H2 2020
Chondrosarcoma - Pipeline by Epizyme Inc, H2 2020
Chondrosarcoma - Pipeline by Forma Therapeutics Inc, H2 2020
Chondrosarcoma - Pipeline by Horizon Therapeutics Plc, H2 2020
Chondrosarcoma - Pipeline by Idera Pharmaceuticals Inc, H2 2020
Chondrosarcoma - Pipeline by ImmunityBio Inc, H2 2020
Chondrosarcoma - Pipeline by Inhibrx Inc, H2 2020
Chondrosarcoma - Pipeline by Karyopharm Therapeutics Inc, H2 2020
Chondrosarcoma - Pipeline by Merck & Co Inc, H2 2020
Chondrosarcoma - Pipeline by Nanode Therapeutics Inc, H2 2020
Chondrosarcoma - Pipeline by Nektar Therapeutics, H2 2020
Chondrosarcoma - Pipeline by Novartis AG, H2 2020
Chondrosarcoma - Pipeline by Ono Pharmaceutical Co Ltd, H2 2020
Chondrosarcoma - Pipeline by Pfizer Inc, H2 2020
Chondrosarcoma - Pipeline by Pharma Mar SA, H2 2020
Chondrosarcoma - Pipeline by Shanghai Junshi Bioscience Co Ltd, H2 2020
Chondrosarcoma - Dormant Projects, H2 2020
Chondrosarcoma - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Chondrosarcoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020

Companies Mentioned
• Aadi Bioscience Inc
• Acrotech Biopharma LLC
• Advenchen Laboratories LLC
• Agios Pharmaceuticals Inc
• Alkermes Plc
• Astex Pharmaceuticals Inc
• Atlanthera
• Bayer AG
• BioAtla LLC
• BioMed Valley Discoveries Inc
• Daiichi Sankyo Co Ltd
• Eli Lilly and Co
• ENB Therapeutics LLC
• Epeius Biotechnologies Corp
• Epizyme Inc
• Forma Therapeutics Inc
• Horizon Therapeutics Plc
• Idera Pharmaceuticals Inc
• ImmunityBio Inc
• Inhibrx Inc
• Karyopharm Therapeutics Inc
• Merck & Co Inc
• Nanode Therapeutics Inc
• Nektar Therapeutics
• Novartis AG
• Ono Pharmaceutical Co Ltd
• Pfizer Inc
• Pharma Mar SA
• Shanghai Junshi Bioscience Co Ltd